HuR activators represent a category of molecules that interact with and modulate the activity of Human antigen R (HuR), a member of the embryonic lethal abnormal vision (ELAV) family of RNA-binding proteins. HuR primarily binds to adenylate-uridylate-rich elements (AREs) found in the 3'-untranslated regions (3'-UTRs) of many mRNAs, affecting their stability and translation. By doing so, HuR plays a crucial role in post-transcriptional gene regulation. HuR activators can enhance this process, leading to increased mRNA stability and thus affecting protein expression. It's important to note that the term HuR activator is somewhat broad, as it may include any molecule that increases HuR activity, either directly by binding to HuR and activating it, or indirectly by affecting pathways that control HuR expression or activity.
The exact mechanisms by which HuR activators function can vary greatly. Some molecules may work by increasing the expression of HuR itself, while others could influence the nuclear-cytoplasmic shuttling of HuR, altering its spatial distribution within the cell. The subcellular localization of HuR is important because it typically binds to mRNAs in the nucleus and then transports them to the cytoplasm, where it can protect the mRNAs from degradation and promote their translation. Therefore, molecules that influence HuR's subcellular localization can indirectly activate HuR. Some HuR activators might also enhance HuR's mRNA-binding activity, leading to increased mRNA stability and translation. It's important to note that the field of HuR activators is still relatively young, and many activators are in the early stages of identification and characterization.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin is a chemotherapy drug that works by crosslinking with the purine bases on the DNA, interfering with DNA repair mechanisms, causing DNA damage, and inducing apoptosis in cancer cells. Increased DNA damage has been associated with increased HuR expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-fluorouracil is a chemotherapy agent that incorporates into RNA and DNA and causes damage, leading to a block in synthesis and function. It has been observed to lead to an increase in HuR cytoplasmic abundance, which can increase the stability of certain mRNAs. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is a chemotherapy and immunosuppressant drug that inhibits the metabolism of folic acid. It has been suggested to increase HuR expression, although the mechanism is not well-understood. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is a chemotherapy agent in research used to treat a wide range of cancers. It works by intercalating DNA, disrupting DNA replication and repair. This agent has been reported to increase HuR expression in certain conditions. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a chemotherapy agent in research that inhibits topoisomerase II, leading to DNA strands breaking during replication. Etoposide has been shown to induce the expression of HuR in some cell lines. | ||||||